BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//RESIST - ECPv6.5.1.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.resist-cluster.de
X-WR-CALDESC:Events for RESIST
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260507T130000
DTEND;TZID=Europe/Berlin:20260507T140000
DTSTAMP:20260417T131041
CREATED:20260410T045757Z
LAST-MODIFIED:20260417T055701Z
UID:40344-1778158800-1778162400@www.resist-cluster.de
SUMMARY:RESIST-Seminar Gastvortrag von Luis Schang\, MV\, PhD
DESCRIPTION:Spannende Themen\, interessant präsentiert: Jeden Donnerstag stellen RESIST-Wissenschaftler:innen oder hochkarätige Forscher:innen aus externen Institutionen bei der RESIST-Seminarreihe ihre Themen vor. \nBesuchen Sie als Mitglied von RESIST oder als Kollegin\, Kollege oder Studierende diese spannenden Seminare des Exzellenzclusters RESIST. \nAm 7. Mai 2026 um 13 Uhr wird Luis Schang\, MV\, PhD\, Professor of Chemical Virology\, Department of Microbiology & Immunology\, Baker Institute for Animal Health\, Cornell University\, einen Vortrag mit dem Titel „HSV-1 and HSV-2 silencing during establishment of latency in human sensory neurons: implications for pathogenesis and therapy“ halten. \n„Despite the effective clinical antivirals approved since the 1980’s\, herpes simplex virus 1 and 2 (HSV-1\, -2) continue to pose major and chronic challenges to human health and well-being. Neonatal infections are life-threatening\, ocular infections are the most prevalent infectious cause of corneal transplants in the Western world\, herpes encephalitis is lethal or result in serious sequelae\, and genital herpes increases the risk of HIV infection\, among many other health problems. Herpes simplex viruses are also the cause of major mental health distress and may be involved in Alzheimer’s and other neurodegenerative diseases.\nThe ability of HSV-1 and 2 to establish life-long latent infections in sensory ganglia is the main barrier to effective management because latent virus does not express viral proteins\, which are the targets of most antivirals and vaccines. Latency is challenging to study\, too. We have developed a new model of latency in human sensory DRG and TG-like neurons and wild-type strains or clinical isolates of HSV-1 and -2. Latency is established with no antivirals\, antibodies\, cytokines\, or viral mutants and a low multiplicity\, reflecting the natural human infection. Using this model\, we will show that HSV-1 and -2 lytic genes are expressed during the acute neuronal infection\, viral genomes replicate and PML bodies are destroyed\, while the infection spreads for about 15-23 days before production of infectious virus ceases. Yet\, infected neurons survive\, PMLs reassemble around compacted genomes\, and the viral genomes persist indefinitely into latency. Viral genomes have positioned nucleosomes on day 7\, but nucleosome occupancy and positioning increased in latency. Four nucleosomes were positioned at and around an origin of DNA replication in latency but not during the acute infection. Reactivation up to 56 days after infection induces gene expression\, DNA replication and production of cell-free infectious virus with genomes replicated during the acute infection. Abortive reactivations may occur periodically in exceedingly rare neurons.\nTogether with the number of latent genomes per neuron in cadaveric human samples and latently infected mice\, and the activation of lytic promoters in mice before the establishment of latency\, these results challenge the conclusion that latency is established exclusively by unreplicated viral genomes with no previous lytic gene expression. These findings impact our understanding of the establishment of latency by herpes simplex viruses and the development of new antivirals acting on the critical stages of latency.“\nDer Vortrag findet im Hörsaal Q\, Gebäude J06 der Medizinischen Hochschule Hannover statt. \nWenn Sie an einer Teilnahme per Video (online) interessiert sind\, wenden Sie sich bitte an RESIST@mh-hannover.de. \nHaben Sie Fragen oder Anregungen zur RESIST-Seminarreihe? Dann nehmen Sie bitte Kontakt mit uns auf.
URL:https://www.resist-cluster.de/veranstaltung/resist-seminar-gastvortrag-luis-schang/
LOCATION:MHH\, Gebäude J6\, Hörsaal Q\, Carl-Neuberg-Str. 1\, Hannover\, 30625
CATEGORIES:Seminar (bevorstehend)
ATTACH;FMTTYPE=image/png:https://www.resist-cluster.de/wp-content/uploads/2026/04/Seminarankuendigung-Schang.png
ORGANIZER;CN="Exzellenzcluster RESIST":MAILTO:RESIST@mh-hannover.de
END:VEVENT
END:VCALENDAR